A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension

Recruiting
18 years - 100 years
All
Phase 3
1 participants needed
1 Location

Brief description of study

Glaucoma treatment study

Detailed description of study

This study is evaluating the duration and safety of a topical medication (Bimatoprost SR) for people who have OAG or OHT.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: OAG,eyes,eye,glaucoma,open-angle glaucoma,ocular hypertension,OHT,POAG,vision
  • Age: 18 years - 100 years
  • Gender: All

Eligibility Criteria
Diagnosis of either OAG (ie, primary OAG, pseudoexfoliation glaucoma,
pigmentary glaucoma) or OHT in the study eye, requiring IOP-lowering treatment
 
Exclusion Criteria
Previous glaucoma eye surgery

Updated on 04 Aug 2024. Study ID: 1904606314

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Zip Code
Please provide your 5-digit zip code
0 0 /250
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team